Clinical Trial

Clinical Study to Determine Bioequivalence of Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Male Subjects Under Fasted Conditions

Name: Clinical Study to Determine Bioequivalence of Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Male Subjects Under Fasted Conditions — clinical trial record (NCT07698275)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ACL25-PC006

Completed

View on ClinicalTrials.gov →

Summary

Prospective, longitudinal, single-dose, randomized, open-label, crossover 2x4, replicated, two treatments, four periods, two sequences controlled clinical study

Trial Details

NCT Number	NCT07698275
Lead Sponsor	ADIUM
Conditions	Bioequivalance
Enrollment	34 participants
Start Date	2026-01-12
Primary Completion	2026-03-19 (estimated)
Study Completion	2026-03-19 (estimated)
Updated on ClinicalTrials.gov	2026-07-13